Welcome to LookChem.com Sign In|Join Free
  • or
C21H24N2O2 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1371989-65-9

Post Buying Request

1371989-65-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1371989-65-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1371989-65-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,1,9,8 and 9 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1371989-65:
(9*1)+(8*3)+(7*7)+(6*1)+(5*9)+(4*8)+(3*9)+(2*6)+(1*5)=209
209 % 10 = 9
So 1371989-65-9 is a valid CAS Registry Number.

1371989-65-9Upstream product

1371989-65-9Downstream Products

1371989-65-9Relevant academic research and scientific papers

Cyclopropyl-spiro-piperidines useful as sodium channel blockers

Blass, Benjamin

, p. 697 - 698 (2012)

Voltage-gated ion channels are critical to the generation and propagation of electrical signals and action potentials in neuronal and muscle tissue. The voltage-gated sodium channels in particular mediate the rapid depolarization of cells, creating the rising phase of an action potential, which in turn activates voltage-gated calcium and potassium channels. To date, nine voltage-gated sodium channel subtypes have been identified, and blockers of these channels have been developed as antiarrhythmic agents, anticonvulsants, antiepileptics, and local anesthetics. Voltage-gated sodium channels have also been targeted for the treatment of neuropathic pain, as it has been established that these channels play a critical role in the nerve cells associated with this condition. Specifically, it has been hypothesized that neuropathic pain is a result of increased sodium channel activity in injured nerves and that selective blockade of sodium channels such as Nav1.7 would provide therapeutic relief. The present application describes a series of cyclopropyl-spiro-piperidines useful as sodium channel blockers for the treatment of chronic and neuropathic pain.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1371989-65-9